Prismaflex Firmware
Monthly
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The PrismaFlex device contains a hard-coded service password that provides access to biomedical information, device settings,. Rated medium severity (CVSS 4.9), this vulnerability is low attack complexity. No vendor patch available.
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit encryption (e.g., TLS/SSL) when configured to send treatment data to a PDMS. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The PrismaFlex device contains a hard-coded service password that provides access to biomedical information, device settings,. Rated medium severity (CVSS 4.9), this vulnerability is low attack complexity. No vendor patch available.